(Q40199788)

English

Haloperidol and the significance of α-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: A behavioral study on cats

scientific article published on December 18, 1978

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Haloperidol and the significance of α-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: A behavioral study on cats (English)

reason for preferred rank

most precise value

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Haloperidol and the significance of alpha-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: a behavioral study on cats (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A215864

13 January 2023

1 reference

based on heuristic

inferred from title

author name string

A. R. Cools

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A215864

13 January 2023

language of work or name

0 references

publication date

1 December 1978

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

18 December 1978

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=215864

13 January 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0024320578901716?httpAccept=text/xml

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

https://api.elsevier.com/content/article/PII:0024320578901716?httpAccept=text/plain

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

2475-2483

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice

1

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines

3

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics

4

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis

5

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol

6

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

An experimental model of tardive dyskinesia

7

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Adrenergic Effect of Chronic Administration of Neuroleptics

8

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

9

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

11

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum

13

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics

14

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

15

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

19

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain

20

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Neuroleptic antagonism of dyskinetic phenomena

21

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain

22

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Evidence for dopamine receptors mediating sedation in the mouse brain

23

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action

24

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Two dopamine receptors: Supportive evidence with the rat rotational model

25

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Ontogenetic development of neostriatal dopamine receptors in the rat.

26

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors

27

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Characterization of dopamine binding sites in standard preparations of brain synaptic membranes

28

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Possible dopaminergic pathway from substantia nigra to putamen.

31

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Molecular Pharmacology

33

14

403

author name string

Peroutka

publication date

1978

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: adaptation to persistent changes in the availability of norepinephrine (NE)

34

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system

35

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Blockade by pimozide of a noradrenaline sensitive adenylate cyclase in the limbic forebrain: possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

36

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

37

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Effect of neuroleptics on endogenous norepinephrine in rat brain

38

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Haloperidol blocks an alpha adrenergic receptor in the reticulo-cortical inhibitory input

39

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain

40

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol

41

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Further evidence for a change in central ?-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment

42

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

43

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

44

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

48

1 reference

10.1016/0024-3205(78)90171-6

https://api.crossref.org/works/10.1016/0024-3205(78)90171-6

13 January 2023

Identifiers

10.1016/0024-3205(78)90171-6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40199788&oldid=1810824093"